BR112012010102A2 - material de resvetimento, uso de materiais de revestimento, e, revestimento de película para formas de dosagem farmacêuticas - Google Patents

material de resvetimento, uso de materiais de revestimento, e, revestimento de película para formas de dosagem farmacêuticas

Info

Publication number
BR112012010102A2
BR112012010102A2 BR112012010102A BR112012010102A BR112012010102A2 BR 112012010102 A2 BR112012010102 A2 BR 112012010102A2 BR 112012010102 A BR112012010102 A BR 112012010102A BR 112012010102 A BR112012010102 A BR 112012010102A BR 112012010102 A2 BR112012010102 A2 BR 112012010102A2
Authority
BR
Brazil
Prior art keywords
dosage forms
pharmaceutical dosage
sealing material
coating
component
Prior art date
Application number
BR112012010102A
Other languages
English (en)
Other versions
BR112012010102B8 (pt
BR112012010102B1 (pt
Inventor
Karl Kolter
Maximilian Angel
Thomas Breiner
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of BR112012010102A2 publication Critical patent/BR112012010102A2/pt
Publication of BR112012010102B1 publication Critical patent/BR112012010102B1/pt
Publication of BR112012010102B8 publication Critical patent/BR112012010102B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10—Esters
    • C08F220/12—Esters of monohydric alcohols or phenols
    • C08F220/14—Methyl esters, e.g. methyl (meth)acrylate
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/01—Use of inorganic substances as compounding ingredients characterized by their specific function
    • C08K3/014—Stabilisers against oxidation, heat, light or ozone
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
    • C08K3/24—Acids; Salts thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
    • C08K3/24—Acids; Salts thereof
    • C08K3/26—Carbonates; Bicarbonates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/005—Stabilisers against oxidation, heat, light, ozone
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/13—Phenols; Phenolates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/16—Nitrogen-containing compounds
    • C08K5/17—Amines; Quaternary ammonium compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/16—Nitrogen-containing compounds
    • C08K5/17—Amines; Quaternary ammonium compounds
    • C08K5/175—Amines; Quaternary ammonium compounds containing COOH-groups; Esters or salts thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10—Esters
    • C08F220/34—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
    • C08K3/24—Acids; Salts thereof
    • C08K3/26—Carbonates; Bicarbonates
    • C08K2003/262—Alkali metal carbonates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
  • Polymerisation Methods In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

material de revestimento, udo de materiais de revestimento, e, revestimentos de película para formas de dosagem farmacêuticas. é descrito material de revestimento, contendo uma mistura de i) um polímero obtido por polimerização de radical de a) n,n-dietilaminoetil metacrilato, e b) pelo menos um composto radicalmente polimerizável, selecionado de ésteres de ácidos mono e dicarboxílicos a,<225>-etilenicamenteinsaturados com alcanóis c ~1~-c ~8~, como componente a, ii) um ou mais antioxidantes como componente b, iii) um ou mais plastificantes como componente c, e iv) outros excipientes como componentes d, em que a quantidade total da mistura de componentes a-d è 100% em peso.
BR112012010102A 2009-10-28 2010-10-21 material de revestimento, uso de materiais de revestimento, e, revestimentos de película para formas de dosagem farmacêuticas BR112012010102B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP09174372 2009-10-28
EP09174372.4 2009-10-28
US25822009P 2009-11-05 2009-11-05
US61/258220 2009-11-05
PCT/EP2010/065848 WO2011051155A2 (en) 2009-10-28 2010-10-21 Stable protective coatings for pharmaceutical dosage forms

Publications (3)

Publication Number Publication Date
BR112012010102A2 true BR112012010102A2 (pt) 2016-05-31
BR112012010102B1 BR112012010102B1 (pt) 2020-12-29
BR112012010102B8 BR112012010102B8 (pt) 2021-05-25

Family

ID=43922667

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012010102A BR112012010102B8 (pt) 2009-10-28 2010-10-21 material de revestimento, uso de materiais de revestimento, e, revestimentos de película para formas de dosagem farmacêuticas

Country Status (6)

Country Link
US (1) US9254329B2 (pt)
EP (1) EP2493452B1 (pt)
JP (1) JP5693594B2 (pt)
CN (1) CN102665688A (pt)
BR (1) BR112012010102B8 (pt)
WO (1) WO2011051155A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2542446C2 (ru) 2010-01-14 2015-02-20 Басф Се Водостойкие косметические композиции, содержащие гидрофобно модифицированный сополимер винилпирролидона
US8962064B2 (en) 2011-02-28 2015-02-24 Basf Se Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms
US8865250B2 (en) 2011-02-28 2014-10-21 Basf Se Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms
CN103347931B (zh) * 2011-02-28 2016-02-17 巴斯夫欧洲公司 制备用于药物剂型的稳定保护性衣层的粉末包衣剂
WO2013128276A2 (en) * 2012-03-02 2013-09-06 Rhodes Pharmaceuticals L.P. Tamper resistant immediate release formulations
US20150017236A1 (en) * 2013-07-09 2015-01-15 Jefferson J. Gregory Pharmaceutical compositions of thyroid hormone
CN108472256A (zh) 2015-12-28 2018-08-31 日本新药株式会社 压缩成型制剂

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1090381B (de) 1958-12-18 1960-10-06 Roehm & Haas Gmbh Verfahren zum UEberziehen von Arzneiformen mit im Magen loeslichen Dragiermassen
DE1219175B (de) 1965-02-24 1966-06-16 Bayer Ag Verfahren zur Herstellung von gegen die Einwirkung von Pansensaeften der Wiederkaeuer geschuetzten Wirkstoffzubereitungen
GB1324087A (en) 1969-07-18 1973-07-18 Commw Scient Ind Res Org Copolymers and veterinary compositions treated therewith
DE2135073C3 (de) 1971-07-14 1974-07-11 Roehm Gmbh Überzugsmittel für Arzneiformen
DE3049179A1 (de) 1975-03-20 1982-07-29 Röhm GmbH, 6100 Darmstadt Bindemittel fuer arzneimittelueberzuege.
DE2512238C2 (de) 1975-03-20 1977-01-13 Roehm Gmbh Bindemittel fuer arzneimittelueberzuege
FR2401620A1 (fr) 1977-09-02 1979-03-30 Eastman Kodak Co Granules indegradables dans la panse des ruminants
US4378445A (en) 1980-06-06 1983-03-29 E. I. Du Pont De Nemours And Company High solids acrylic dispersion lacquer
DE3106449A1 (de) 1981-02-20 1982-09-09 Röhm GmbH, 6100 Darmstadt "in magensaft loesliche oder quellbare ueberzugsmasse und ihre verwendung in einem verfahren zum ueberziehen von arzneiformen"
DE3426587A1 (de) 1984-07-19 1986-01-30 Röhm GmbH, 6100 Darmstadt Verfahren zum ueberziehen von arzneiformen
FR2781152B1 (fr) 1998-07-20 2001-07-06 Permatec Tech Ag Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation
DE19918435A1 (de) 1998-07-23 2000-01-27 Roehm Gmbh Überzugs- und Bindemittel für orale oder dermale Arzneiformen
CA2403831C (en) 2001-02-27 2009-11-24 Rohm Gmbh & Co. Kg Coating and binding agent for pharmaceutical formulations having improved storage stability
US7332182B2 (en) * 2001-08-06 2008-02-19 Purdue Pharma L.P. Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
DE10239999A1 (de) 2002-08-27 2004-03-04 Röhm GmbH & Co. KG Granulat oder Pulver zur Herstellung von Überzugs- und Bindemitteln für Arzneiformen
WO2005056619A1 (en) 2003-12-15 2005-06-23 Council Of Scientific & Industrial Research pH SENSITIVE POLYMER AND PROCESS FOR PREPARATION THEREOF
CN1878540B (zh) 2003-12-15 2012-02-29 科学与工业研究委员会 含pH敏感性聚合物的掩味的药物组合物
US8425935B2 (en) 2005-12-21 2013-04-23 Basf Se Pharmaceutical formulation for producing rapidly disintegrating tablets
EP2176301B1 (de) 2007-08-02 2013-05-15 Basf Se Wässrige polymerdispersion auf basis von n, n-diethylaminoethylmethacrylat, deren herstellung und verwendung
MX2011000994A (es) 2008-08-01 2011-03-04 Basf Se Metodo para producir fenilalcan-1-oles.
US8692025B2 (en) 2009-10-23 2014-04-08 Basf Se Process for preparing M- or P-substituted phenylalkanols by alkylation
JP5758906B2 (ja) 2009-10-23 2015-08-05 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 異性化によるｍ−置換フェニルアルカノールの製造方法

Also Published As

Publication number Publication date
EP2493452A2 (en) 2012-09-05
WO2011051155A3 (en) 2011-12-08
US9254329B2 (en) 2016-02-09
JP2013509368A (ja) 2013-03-14
BR112012010102B8 (pt) 2021-05-25
US20120214917A1 (en) 2012-08-23
WO2011051155A2 (en) 2011-05-05
JP5693594B2 (ja) 2015-04-01
EP2493452B1 (en) 2013-07-17
BR112012010102B1 (pt) 2020-12-29
CN102665688A (zh) 2012-09-12

Similar Documents

Publication Publication Date Title
BR112012010102A2 (pt) material de resvetimento, uso de materiais de revestimento, e, revestimento de película para formas de dosagem farmacêuticas
UA109122C2 (uk) Синергічна гербіцидна композиція, яка містить амінопіралід і 2,4-дихлорфеноксіоцтову кислоту
BR112014017579A8 (pt) polímeros de silicone contendo grupos ácido sulfônico
BR112015021665A2 (pt) misturas de isômeros de (metilciclohe-xil)tolueno, sua produção e uso na fabricação de plastificantes
ES2531077T3 (es) Métodos y composiciones relacionadas con el reciclaje de residuos poliméricos
BR112014013308A2 (pt) polímero superabsorvente com reticulador
BR112013031268A8 (pt) polipeptídeos
BR112013033536A2 (pt) composição de resina formadora de folha de fósforo
BR112018013117A2 (pt) revestimentos de barreiras a base de água
BR112013028453B8 (pt) Uso de uma composição de revestimento, formas de dosagem farmacêuticas ou nutracêuticas gastrorresistentes, e composição do polímero do núcleo/invólucro
ES2517419T3 (es) Artículos adhesivos para dentadura postiza
BR112012029566A2 (pt) composição.
BR112015020979A2 (pt) uso de compostos termoplásticos de moldagem e corpo de moldagem
BR112012023283A2 (pt) cosmético de cabelo
ES2627114T3 (es) Composición estabilizada que comprende homopolímeros o copolímeros de etileno y antioxidantes naturales
BR112013032095A2 (pt) composição de revestimento adequada para formas de dosagem farmacêuticas ou nutracêuticas
BRPI0914225A8 (pt) Método de preparação de uma composição farmacêutica de formas galênicas de liberação controlada de relaxantes do músculo-esquelético
MX351429B (es) Materiales dentales basados en monómeros con propiedades de despegado según sea necesario.
BR112012021099A2 (pt) composição de borracha de copolímero, produto reticulado de borracha, laminado, e, mangueira
BRPI0607464A2 (pt) adesivo e emplastro adesivo
BR112016028635A2 (pt) artigo absorvente com adesivo isento de agente de pegajosidade
AR053691A1 (es) Agentes endoparasiticidas
AR084295A1 (es) Dispersion acuosa polimerica que contiene almidon, proceso para su preparacion y utilizacion
BR112013020877A2 (pt) processo para produzir composições de revestimento pulverulentas, uso de um pó de polímero obtido, e, pó de polímero obtido
BR112014028527A2 (pt) formulação de cura anaeróbica, uso da formulação e método para micro-encapsulamento de um acelerador de polimerização

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/12/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/10/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B22B Petition not considered [chapter 22.2 patent gazette]

Free format text: NAO CONHECIDA A PETICAO NO 870210067280, DE 23/07/2021, EM VIRTUDE DO DISPOSTO NO ART. 219 , INCISO II DA LPI